From: Exposure to statins and risk of common cancers: a series of nested case-control studies
 | Atorvastatin | Pravastatin | Simvastatin | ||||||
---|---|---|---|---|---|---|---|---|---|
cancer | Cases/Controls | Adjusted Odds ratio (95%CI) # | P-value | Cases/Controls | Adjusted Odds ratio (95%CI) # | P-value | Cases/Controls | Adjusted Odds ratio (95%CI) # | P-value |
breast†| 596/2574 | 0.96 (0.86 to 1.06) | 0.387 | 152/630 | 1.02 (0.85 to 1.23) | 0.835 | 871/3720 | 0.98 (0.89 to 1.07) | 0.584 |
prostate | 1023/4398 | 0.99 (0.91 to 1.07) | 0.781 | 314/1182 | 1.15 (1.00 to 1.31) | 0.046 | 1668/6924 | 1.05 (0.99 to 1.13) | 0.117 |
colorectal‡ | 826/2934 | 1.17 (1.07 to 1.28) | 0.001 | 212/786 | 1.09 (0.93 to 1.28) | 0.289 | 1152/4783 | 0.96 (0.88 to 1.04) | 0.273 |
lung | 786/2912 | 1.07 (0.97 to 1.18) | 0.179 | 195/837 | 0.93 (0.78 to 1.11) | 0.435 | 1205/4588 | 1.06 (0.97 to 1.15) | 0.202 |
blood | 381/1653 | 0.87 (0.77 to 0.99) | 0.041 | 95/452 | 0.84 (0.66 to 1.06) | 0.138 | 579/2592 | 0.82 (0.73 to 0.91) | < 0.001 |
bladder | 353/1212 | 1.19 (1.03 to 1.37) | 0.015 | 87/309 | 1.08 (0.84 to 1.40) | 0.544 | 513/1893 | 1.10 (0.97 to 1.25) | 0.119 |
skin | 168/655 | 1.03 (0.84 to 1.25) | 0.805 | 43/178 | 0.91 (0.64 to 1.30) | 0.609 | 259/998 | 1.06 (0.90 to 1.26) | 0.483 |
oesophagus | 197/846 | 0.88 (0.73 to 1.05) | 0.159 | 62/226 | 1.05 (0.78 to 1.42) | 0.740 | 298/1222 | 0.94 (0.80 to 1.09) | 0.403 |
pancreas | 143/557 | 0.92 (0.74 to 1.14) | 0.439 | 37/152 | 0.92 (0.62 to 1.35) | 0.667 | 224/852 | 0.99 (0.83 to 1.20) | 0.952 |
stomach | 123/500 | 0.94 (0.75 to 1.18) | 0.604 | 41/149 | 1.03 (0.71 to 1.50) | 0.880 | 186/819 | 0.85 (0.70 to 1.03) | 0.106 |
All cancers | 5357/21253 | 1.01 (0.98 to 1.05) | 0.461 | 1442/5680 | 1.02 (0.96 to 1.09) | 0.488 | 8102/32769 | 1.00 (0.97 to 1.03) | 0.844 |